Chen Y, Yang J, Du Y, Yan Z, Gao J, Zhang H
Discov Oncol. 2025; 16(1):173.
PMID: 39945932
PMC: 11825422.
DOI: 10.1007/s12672-025-01917-5.
Salinas E, Ruano-Rivadeneira F, Leal J, Caprile T, Torrejon M, Arriagada C
Front Cell Dev Biol. 2025; 12():1457506.
PMID: 39834387
PMC: 11743681.
DOI: 10.3389/fcell.2024.1457506.
Fontana F, Sommariva M, Anselmi M, Bianchi F, Limonta P, Gagliano N
Cells. 2024; 13(2).
PMID: 38247872
PMC: 10814891.
DOI: 10.3390/cells13020181.
den Hollander P, Maddela J, Mani S
Clin Chem. 2024; 70(1):190-205.
PMID: 38175600
PMC: 11246550.
DOI: 10.1093/clinchem/hvad197.
Imodoye S, Adedokun K
Clin Exp Med. 2023; 23(8):4265-4287.
PMID: 37966552
DOI: 10.1007/s10238-023-01229-4.
Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis.
Jimenez S, Piera-Velazquez S
Curr Rheumatol Rev. 2023; 20(4):388-404.
PMID: 37921216
DOI: 10.2174/0115733971261932231025045400.
Helicobacter pylori-activated fibroblasts as a silent partner in gastric cancer development.
Krzysiek-Maczka G, Brzozowski T, Ptak-Belowska A
Cancer Metastasis Rev. 2023; 42(4):1219-1256.
PMID: 37460910
PMC: 10713772.
DOI: 10.1007/s10555-023-10122-1.
FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis.
Caredda E, Pedini G, DAmico F, Scioli M, Pacini L, Orsaria P
PLoS One. 2023; 18(6):e0287062.
PMID: 37379311
PMC: 10306178.
DOI: 10.1371/journal.pone.0287062.
Combating pancreatic cancer with ovarian cancer cells.
Lin X, Cui C, Cui Q
Aging (Albany NY). 2023; 15(6):2189-2207.
PMID: 36961421
PMC: 10085619.
DOI: 10.18632/aging.204608.
Emerging mechanisms progress of colorectal cancer liver metastasis.
Zhao W, Dai S, Yue L, Xu F, Gu J, Dai X
Front Endocrinol (Lausanne). 2022; 13:1081585.
PMID: 36568117
PMC: 9772455.
DOI: 10.3389/fendo.2022.1081585.
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D, Price Z, Lokman N, Wang W, Goonetilleke L, Kadife E
J Transl Med. 2022; 20(1):556.
PMID: 36463238
PMC: 9719259.
DOI: 10.1186/s12967-022-03776-y.
Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An study.
Lee J, Hong E, Kim J, Kim J, Jung J, Park S
Oncol Lett. 2022; 24(6):448.
PMID: 36420069
PMC: 9647786.
DOI: 10.3892/ol.2022.13568.
Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.
Marona P, Gorka J, Kwapisz O, Jura J, Rys J, Hoffman R
Cell Death Dis. 2022; 13(9):814.
PMID: 36138026
PMC: 9500022.
DOI: 10.1038/s41419-022-05251-4.
Phenotypic Plasticity - Alternate Transcriptional Programs Driving Treatment Resistant Prostate Cancer.
Nanda J, Koganti P, Perri G, Ellis L
Crit Rev Oncog. 2022; 27(1):45-60.
PMID: 35993978
PMC: 10353263.
DOI: 10.1615/CritRevOncog.2022043096.
Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching.
Chen C, Zhao S, Zhao X, Cao L, Karnad A, Kumar A
Cell Death Dis. 2022; 13(8):682.
PMID: 35931675
PMC: 9355957.
DOI: 10.1038/s41419-022-05103-1.
SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
Lopez-Moncada F, Torres M, Lavanderos B, Cerda O, Castellon E, Contreras H
Int J Mol Sci. 2022; 23(11).
PMID: 35682554
PMC: 9180154.
DOI: 10.3390/ijms23115874.
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review.
Sheikh E, Tran T, Vranic S, Levy A, Bonfil R
Bosn J Basic Med Sci. 2022; 22(5):683-698.
PMID: 35490363
PMC: 9519160.
DOI: 10.17305/bjbms.2021.7399.
The Immunohistochemical Expression of SOX-10 in Urothelial Carcinoma and the Non Neoplastic Urothelium; and a Correlation with the Tumor Features.
Amer S, Ibrahim H, Elkordy M
Asian Pac J Cancer Prev. 2022; 23(4):1425-1432.
PMID: 35485705
PMC: 9375602.
DOI: 10.31557/APJCP.2022.23.4.1425.
LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility.
Su Y, Gu X, Zheng Q, Zhu L, Lu J, Li L
Front Oncol. 2022; 12:847745.
PMID: 35265529
PMC: 8898824.
DOI: 10.3389/fonc.2022.847745.
Golgi phosphoprotein 3 induces autophagy and epithelial-mesenchymal transition to promote metastasis in colon cancer.
Gong L, Tu T, Zhu J, Hu A, Song J, Huang J
Cell Death Discov. 2022; 8(1):76.
PMID: 35190555
PMC: 8861175.
DOI: 10.1038/s41420-022-00864-2.